Clinical Trials on Nutritional and Metabolic Diseases in Austria

Total 16285 results

Austin Health

Completed

Reandron in Diabetic Men Witn Low Testosterone Level

Type 2 Diabetes | Hypogonadism

Australia
Roxane Laboratories

Completed

Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions

Hypertension

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes (DAD)

Diabetes

United States
Merck KGaA, Darmstadt, Germany
Merck Gesellschaft mbH, Austria

Completed

Bisoprolol in Hypertension: Effect on Concomitant Elevated Heart Rate

Hypertension

Austria
Unilever R&D
Commonwealth Scientific and Industrial Research Organisation, Australia

Completed

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

Vascular Diseases | Diabetes Mellitus | Hypercholesterolemia

Australia
Sanofi

Completed

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (REASSURE)

Diabetes Mellitus, Type 2

Australia
University of Sydney
Northern Care Alliance NHS Foundation Trust; Waitemata District Health Board; Australasian Kidney Trials Network

Recruiting

Better Evidence and Translation for Calciphylaxis (BEAT-Calci)

Calciphylaxis

Australia, New Zealand
Olivia Newton-John Cancer Research Institute
Austin Health; La Trobe University

Recruiting

Medical Imaging of Cachexia

Cancer Cachexia

Australia
Melbourne Health
National Health and Medical Research Council, Australia; Juvenile Diabetes...

Active, not recruiting

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes (IAA)

Diabetes Mellitus, Type 1 | Type 1 Diabetes

Australia
Cephalon

Terminated

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Osteoporosis | Bone Loss

Australia
Apollo Endosurgery, Inc.

Completed

LAP-BAND AP Early Experience Trial (APEX)

Obesity, Morbid

United States
Erbe Elektromedizin GmbH
ERBE AUSTRALIA PTY LTD

Recruiting

HybridAPC for Gastric Mucosal Ablation in Obese Patients.

Obesity | Adiposity

Australia
University of Texas at Austin
Meals on Wheels Central Texas

Enrolling by invitation

Meals for Me: Drop Shipment Versus Personally-delivered Meals for Diabetes Management

Diabetes

United States
University of Texas at Austin

Completed

Effect of Daily Steps on Fat Metabolism

Atherosclerosis | Metabolic Syndrome

United States
Solarea Bio, Inc

Active, not recruiting

Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia

Osteopenia

Australia
Menzies Institute for Medical Research

Completed

The Effectiveness of Individualised Bone Density Feedback and Osteoporosis Education in Premenopausal Women

Osteoporosis

Australia
Medical University of Graz
Technical University of Munich; Paracelsus Medical University; University of... and other collaborators

Recruiting

Observational Study of Early Metabolic and Vascular Changes in Obesity (STYJOBS)

Inflammation | Obesity | Atherosclerosis | Fatty Liver | Adiponectin Deficiency

Austria
Medical University of Vienna

Completed

B-type Natriuretic Peptide and Glucose Metabolism

Diabetes Mellitus | Cardiomyopathy

Austria
St Vincent's Hospital Melbourne
Juvenile Diabetes Research Foundation; Medtronic

Completed

The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes

Type 1 Diabetes

Australia
Kirby Institute
National Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaborators

Completed

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Glucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | Lipodystrophy

Australia
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

Hypertension

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Terminated

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
GlaxoSmithKline

Completed

A Drug Interaction Study Between Simvastatin and GSK376501

Type 2 Diabetes Mellitus

United States
Zealand Pharma
SynteractHCR

Completed

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Hypoglycemia | Diabetes Mellitus, Type 1

United States, Austria, Canada, Germany
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
AstraZeneca

Completed

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Type 2 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany, Poland, United Kingdom, Denmark, France, Austria, Czech Republic, Australia
University of Adelaide
Royal Adelaide Hospital

Completed

Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air (HOTAIR4)

Insulin Resistance | Diabetes Mellitus, Type II

Australia
Melbourne Health

Completed

Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes (INITII)

Type 1 Diabetes

Australia, New Zealand
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia

United States, Netherlands, Australia, Austria, Canada, France, Greece, Italy, Japan, South Africa, Ukraine
Novartis Pharmaceuticals

Completed

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications (Navigator)

Diabetes Mellitus, Type 2

Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
Medical University of Graz

Recruiting

ESAN II - Energy Sensing in Depression

Depression | Obesity | Microbial Colonization | Diet, Healthy | Immune System Tolerance

Austria
Amgen

Terminated

Study to Evaluate the Safety of Repatha® in Pregnancy

Pregnancy | Hypercholesterolaemia

Belgium, Denmark, Italy, Czechia, United Kingdom, Australia, Austria, Greece, Switzerland, Netherlands, Spain, Sweden, Slovakia, Norway
Bayside Health

Completed

Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans

Obesity | Insulin Resistance | Type 2 Diabetes

Australia
AstraZeneca

Completed

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Diabetes Mellitus | Peripheral Vascular Diseases | Atherosclerosis | Carotid Stenosis | Hyperlipidemias | Coronary Heart Disease

Austria
University of Adelaide
Central Adelaide Local Health Network Incorporated

Unknown

Quality of Life After Bariatric Surgery

Quality of Life | Obesity | Obesity, Morbid | Bariatric Surgery Candidate

Australia
Medical University of Graz
Austrian Science Fund (FWF)

Completed

Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism

Healthy | Polycystic Ovary Syndrome | Vitamin D Deficiency

Austria
Novo Nordisk A/S

Completed

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Russian Federation, United Kingdom, Canada, Belgium, Germany, Australia
Medical University of Vienna

Completed

Antipsychotics and Gene Expression in Soft Tissues

Diabetes | Schizophrenia

Austria
Medical University of Vienna
Vienna Dialysis Center

Recruiting

SGLT2 Inhibition in Hemodialysis (DAPA-HD)

Diabetes Mellitus, Type 2 | Hemodialysis | Chronic Kidney Disease | Kidney Failure | Left Ventricular Hypertrophy

Austria
Mondelēz International, Inc.
University of Sydney

Completed

Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone.

Metabolic Disorder; Carbohydrate, Absorption, Intestine

Australia
National Institute of Diabetes and Digestive and...

Completed

Education and Group Support for Diabetic Hispanics

Diabetes Mellitus, Non-Insulin-Dependent

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Not yet recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
Medical University of Vienna

Completed

Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection (2007-005020-33)

Soft Tissue Infection

Austria
University of Texas at Austin

Active, not recruiting

Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans (TXSTRIDE)

Type 2 Diabetes

United States
AstraZeneca

Completed

Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants

Type 2 Diabetes Mellitus

United States

Clinical Trials on Nutritional and Metabolic Diseases in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations